EVH vs. AMTM, MARA, RELY, TNET, ATHM, ALIT, CARG, QBTS, DXC, and STNE
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Amentum (AMTM), MARA (MARA), Remitly Global (RELY), TriNet Group (TNET), Autohome (ATHM), Alight (ALIT), CarGurus (CARG), D-Wave Quantum (QBTS), DXC Technology (DXC), and StoneCo (STNE). These companies are all part of the "business services" industry.
Evolent Health vs.
Evolent Health (NYSE:EVH) and Amentum (NYSE:AMTM) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, community ranking, earnings, dividends and profitability.
Amentum has a net margin of 0.00% compared to Evolent Health's net margin of -2.41%. Evolent Health's return on equity of 5.73% beat Amentum's return on equity.
Evolent Health currently has a consensus price target of $17.71, suggesting a potential upside of 90.27%. Amentum has a consensus price target of $26.20, suggesting a potential upside of 39.58%. Given Evolent Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Evolent Health is more favorable than Amentum.
39.9% of Amentum shares are held by institutional investors. 1.6% of Evolent Health shares are held by insiders. Comparatively, 18.7% of Amentum shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Evolent Health received 572 more outperform votes than Amentum when rated by MarketBeat users. Likewise, 74.77% of users gave Evolent Health an outperform vote while only 37.50% of users gave Amentum an outperform vote.
In the previous week, Amentum had 8 more articles in the media than Evolent Health. MarketBeat recorded 16 mentions for Amentum and 8 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.09 beat Amentum's score of 1.05 indicating that Evolent Health is being referred to more favorably in the media.
Amentum has higher revenue and earnings than Evolent Health.
Summary
Evolent Health beats Amentum on 9 of the 16 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
This page (NYSE:EVH) was last updated on 3/25/2025 by MarketBeat.com Staff
